BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20585628)

  • 21. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional repression by the Rb-related protein p107.
    Zamanian M; La Thangue NB
    Mol Biol Cell; 1993 Apr; 4(4):389-96. PubMed ID: 7685208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.
    Liban TJ; Thwaites MJ; Dick FA; Rubin SM
    J Mol Biol; 2016 Oct; 428(20):3960-3971. PubMed ID: 27567532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    Helt AM; Galloway DA
    J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
    Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
    Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2.
    Smith EJ; Nevins JR
    Mol Cell Biol; 1995 Jan; 15(1):338-44. PubMed ID: 7799940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of glutamine metabolism by the tumor suppressor Rb.
    Reynolds MR; Lane AN; Robertson B; Kemp S; Liu Y; Hill BG; Dean DC; Clem BF
    Oncogene; 2014 Jan; 33(5):556-66. PubMed ID: 23353822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
    Timchenko NA; Wilde M; Darlington GJ
    Mol Cell Biol; 1999 Apr; 19(4):2936-45. PubMed ID: 10082561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
    Fattaey AR; Harlow E; Helin K
    Mol Cell Biol; 1993 Dec; 13(12):7267-77. PubMed ID: 8246949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new component of the transcription factor DRTF1/E2F.
    Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
    Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
    Markey MP; Bergseid J; Bosco EE; Stengel K; Xu H; Mayhew CN; Schwemberger SJ; Braden WA; Jiang Y; Babcock GF; Jegga AG; Aronow BJ; Reed MF; Wang JY; Knudsen ES
    Oncogene; 2007 Sep; 26(43):6307-18. PubMed ID: 17452985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geminin is targeted for repression by the retinoblastoma tumor suppressor pathway through intragenic E2F sites.
    Markey M; Siddiqui H; Knudsen ES
    J Biol Chem; 2004 Jul; 279(28):29255-62. PubMed ID: 15084580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle.
    Oswald F; Dobner T; Lipp M
    Mol Cell Biol; 1996 May; 16(5):1889-95. PubMed ID: 8628255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
    Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sin3B: an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawal.
    Grandinetti KB; David G
    Cell Cycle; 2008 Jun; 7(11):1550-4. PubMed ID: 18469515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
    Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
    Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
    Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
    J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription.
    Datta PK; Raychaudhuri P; Bagchi S
    Mol Cell Biol; 1995 Oct; 15(10):5444-52. PubMed ID: 7565695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.